tiprankstipranks
Daehan Nupharm Co., Ltd. (KR:054670)
:054670
South Korea Market

Daehan Nupharm Co., Ltd. (054670) Price & Analysis

Followers

054670 Stock Chart & Stats

₩5600.00
₩210.00(3.90%)
--

054670 FAQ

What was Daehan Nupharm Co., Ltd.’s price range in the past 12 months?
Daehan Nupharm Co., Ltd. lowest stock price was ₩5030.00 and its highest was ₩7900.00 in the past 12 months.
    What is Daehan Nupharm Co., Ltd.’s market cap?
    Daehan Nupharm Co., Ltd.’s market cap is ₩75.65B.
      When is Daehan Nupharm Co., Ltd.’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were Daehan Nupharm Co., Ltd.’s earnings last quarter?
      Daehan Nupharm Co., Ltd. released its earnings results on May 13, 2026. The company reported ₩213.591 earnings per share for the quarter, beating the consensus estimate of N/A by ₩213.591.
        Is Daehan Nupharm Co., Ltd. overvalued?
        According to Wall Street analysts Daehan Nupharm Co., Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Daehan Nupharm Co., Ltd. pay dividends?
          Daehan Nupharm Co., Ltd. does not currently pay dividends.
          What is Daehan Nupharm Co., Ltd.’s EPS estimate?
          Daehan Nupharm Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Daehan Nupharm Co., Ltd. have?
          Daehan Nupharm Co., Ltd. has 14,354,920 shares outstanding.
            What happened to Daehan Nupharm Co., Ltd.’s price movement after its last earnings report?
            Daehan Nupharm Co., Ltd. reported an EPS of ₩213.591 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.627%.
              Which hedge fund is a major shareholder of Daehan Nupharm Co., Ltd.?
              Currently, no hedge funds are holding shares in KR:054670
              What is the TipRanks Smart Score and how is it calculated?
              Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                Daehan Nupharm Co., Ltd. (054670) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Sam-A Pharm. Co., Ltd.
                Osang Healthcare Co. Ltd.
                iNtRON Biotechnology, Inc.
                Optipharm Co., Ltd.
                Enzychem Lifesciences Corp.
                Popular Stocks